BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

312 related articles for article (PubMed ID: 8678926)

  • 1. In vitro lipolysis of human VLDL: effect of different VLDL compositions in normolipidemia, familial combined hyperlipidemia and familial hypertriglyceridemia.
    van Barlingen HH; Kock LA; de Man FH; Erkelens DW; de Bruin TW
    Atherosclerosis; 1996 Mar; 121(1):75-84. PubMed ID: 8678926
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Integrated regulation of very low density lipoprotein triglyceride and apolipoprotein-B kinetics in man: normolipemic subjects, familial hypertriglyceridemia and familial combined hyperlipidemia.
    Kissebah AH; Alfarsi S; Adams PW
    Metabolism; 1981 Sep; 30(9):856-68. PubMed ID: 7266376
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plasma lipoproteins in familial combined hyperlipidemia and monogenic familial hypertriglyceridemia.
    Brunzell JD; Albers JJ; Chait A; Grundy SM; Groszek E; McDonald GB
    J Lipid Res; 1983 Feb; 24(2):147-55. PubMed ID: 6403642
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Influence of lipoprotein lipase and hepatic lipase on the transformation of VLDL and HDL during lipolysis of VLDL.
    Murdoch SJ; Breckenridge WC
    Atherosclerosis; 1995 Dec; 118(2):193-212. PubMed ID: 8770314
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Kinetics of in vitro lipolysis of human very low-density lipoprotein by lipoprotein lipase.
    Schreier L; Berg G; Zago V; Gonzalez AI; Wikinski R
    Nutr Metab Cardiovasc Dis; 2002 Feb; 12(1):13-8. PubMed ID: 12125224
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lipolytic degradation of human very low density lipoproteins by human milk lipoprotein lipase: the identification of lipoprotein B as the main lipoprotein degradation product.
    Alaupovic P; Wang CS; McConathy WJ; Weiser D; Downs D
    Arch Biochem Biophys; 1986 Jan; 244(1):226-37. PubMed ID: 3080947
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reduced lipolysis of large apo E-poor very-low-density lipoprotein subfractions from type IV hypertriglyceridemic subjects in vitro and in vivo.
    Evans AJ; Wolfe BM; Strong WL; Huff MW
    Metabolism; 1993 Jan; 42(1):105-15. PubMed ID: 8446037
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Metabolic consequences of genetic heterogeneity of lipoprotein composition (lipoprotein heterogeneity).
    Brunzell JD; Chait A; Albers JJ; Foster DM; Failor RA; Bierman EL
    Am Heart J; 1987 Feb; 113(2 Pt 2):583-8. PubMed ID: 3812212
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Resistance of chylomicron and VLDL remnants to post-heparin lipolysis in ApoE-deficient mice: the role of apoE in lipoprotein lipase-mediated lipolysis in vivo and in vitro.
    Zsigmond E; Fuke Y; Li L; Kobayashi K; Chan L
    J Lipid Res; 1998 Sep; 39(9):1852-61. PubMed ID: 9741698
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Postprandial remnant-like lipoproteins in hypertriglyceridemia.
    Ooi TC; Cousins M; Ooi DS; Steiner G; Uffelman KD; Nakajima K; Simo IE
    J Clin Endocrinol Metab; 2001 Jul; 86(7):3134-42. PubMed ID: 11443178
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Plasma lipoproteins, apolipoproteins, and triglyceride metabolism in familial hypertriglyceridemia.
    Stalenhoef AF; Demacker PN; Lutterman JA; van 't Laar A
    Arteriosclerosis; 1986; 6(4):387-94. PubMed ID: 3729796
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mechanism of hypertriglyceridemia in human apolipoprotein (apo) CIII transgenic mice. Diminished very low density lipoprotein fractional catabolic rate associated with increased apo CIII and reduced apo E on the particles.
    Aalto-Setälä K; Fisher EA; Chen X; Chajek-Shaul T; Hayek T; Zechner R; Walsh A; Ramakrishnan R; Ginsberg HN; Breslow JL
    J Clin Invest; 1992 Nov; 90(5):1889-900. PubMed ID: 1430212
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of apolipoprotein E variants on lipolysis of very low density lipoproteins by heparan sulphate proteoglycan-bound lipoprotein lipase.
    de Man FH; de Beer F; van de Laarse A; Smelt AH; Leuven JA; Havekes LM
    Atherosclerosis; 1998 Feb; 136(2):255-62. PubMed ID: 9543096
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Apolipoprotein AI and AII metabolism in patients with primary high-density lipoprotein deficiency associated with familial hypertriglyceridemia.
    Saku K; Gartside PS; Hynd BA; Mendoza SG; Kashyap ML
    Metabolism; 1985 Aug; 34(8):754-64. PubMed ID: 3927110
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of fish oil concentrate on lipoproteins and apolipoproteins in familial combined hyperlipidemia.
    Tatò F; Keller C; Wolfram G
    Clin Investig; 1993 Apr; 71(4):314-8. PubMed ID: 8471818
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Low density lipoprotein metabolism in familial combined hyperlipidemia. Mechanism of the multiple lipoprotein phenotypic expression.
    Kissebah AH; Alfarsi S; Evans DJ
    Arteriosclerosis; 1984; 4(6):614-24. PubMed ID: 6508636
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Structural peculiarities of the binding of very low density lipoproteins and low density lipoproteins to the LDL receptor in hypertriglyceridemia: role of apolipoprotein E.
    Dergunov AD; Smirnova EA; Merched A; Visvikis S; Siest G; Yakushkin VV; Tsibulsky V
    Biochim Biophys Acta; 2000 Feb; 1484(1):29-40. PubMed ID: 10685028
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of heparin-induced lipolysis on the distribution of apolipoprotein e among lipoprotein subclasses. Studies with patients deficient in hepatic triglyceride lipase and lipoprotein lipase.
    Rubinstein A; Gibson JC; Paterniti JR; Kakis G; Little A; Ginsberg HN; Brown WV
    J Clin Invest; 1985 Feb; 75(2):710-21. PubMed ID: 3973025
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lipolysis is a prerequisite for lipid accumulation in HepG2 cells induced by large hypertriglyceridemic very low density lipoproteins.
    Evans AJ; Sawyez CG; Wolfe BM; Huff MW
    J Biol Chem; 1992 May; 267(15):10743-51. PubMed ID: 1587849
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Apolipoprotein B metabolism in subjects with deficiency of apolipoproteins CIII and AI. Evidence that apolipoprotein CIII inhibits catabolism of triglyceride-rich lipoproteins by lipoprotein lipase in vivo.
    Ginsberg HN; Le NA; Goldberg IJ; Gibson JC; Rubinstein A; Wang-Iverson P; Norum R; Brown WV
    J Clin Invest; 1986 Nov; 78(5):1287-95. PubMed ID: 3095375
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.